Pharmacology PNLE Practice Questions
Introduction
The live Pharmacology inventory contains 250 original PNLE-style practice questions. It was last updated August 12, 2026. Use the set to connect a drug’s action with a patient cue, then choose a safe nursing response.
The canonical scope covers drug mechanisms, medication classes, therapeutic selection, interactions, toxicity, contraindications, and class-specific monitoring. Learners practice deciding why a medication fits a therapeutic goal, which finding may signal harm, what patient factor changes selection, and what monitoring or teaching supports safe use. Questions focus away from administration technique alone and from disease management when the drug is incidental.
Pharmacology is a cross-cutting practice area mapped across relevant competencies in the official five-subject PNLE TOS. The 2025 Enhanced TOS provides broad competency relationships rather than a guaranteed weight for a pharmacology microtopic, class, or drug. Use this inventory to strengthen medication reasoning across areas such as cardiovascular, endocrine, psychotropic, anti-infective, neurologic, and special-population pharmacology.
Key concepts
- Match the mechanism to the patient cue
Recognize: Identify the drug class, intended action, expected therapeutic effect, and findings that could represent an exaggerated or harmful response.
Decide: Link the assessment finding to the medication’s mechanism before selecting an intervention or escalation.
Avoid: Choosing an answer because the symptom belongs to the patient’s disease when the medication may explain the change. - Select therapy by goal and patient context
Recognize: Separate the immediate therapeutic goal from long-term disease control, symptom relief, prevention, or treatment of toxicity.
Decide: Choose the class or medication that fits the stated purpose and the patient factors presented in the item.
Avoid: Selecting the most familiar drug without checking whether its therapeutic purpose matches the question. - Screen interactions and contraindications
Recognize: Review prescribed medicines, over-the-counter products, supplements, substances, allergies, and conditions that can increase medication risk.
Decide: Identify when the combination requires withholding, clarification, closer monitoring, or urgent action according to the clinical cue.
Avoid: Treating each medication as an isolated fact and overlooking a high-risk combination or patient factor. - Prioritize suspected toxicity
Recognize: Look for new, severe, or rapidly worsening findings after a medication, especially a cluster that suggests systemic toxicity.
Decide: Prioritize immediate assessment, safety, and escalation while connecting the response to the suspected drug-related mechanism.
Avoid: Repeating a dose or treating only one visible symptom before assessing the patient’s overall stability. - Use class-specific monitoring
Recognize: Determine which assessment, laboratory trend, therapeutic response, or adverse effect is relevant to the medication class.
Decide: Monitor the measure that shows benefit and the measure that warns of harm, then interpret both with the patient’s condition.
Avoid: Listing generic monitoring without explaining why that measure matters for the selected drug. - Respect medication time course
Recognize: Distinguish onset, duration, expected therapeutic response, delayed benefit, and time-sensitive adverse effects.
Decide: Make teaching and evaluation fit the medication’s expected timeline and therapeutic goal.
Avoid: Promising immediate improvement or labeling therapy ineffective before the relevant response period has been considered. - Adjust reasoning for special populations
Recognize: Check age, organ function, pregnancy or lactation status when presented, comorbidities, polypharmacy, and the patient’s ability to follow monitoring or teaching.
Decide: Select the safest action using the patient-specific risk, ordered parameters, and required follow-up.
Avoid: Applying an adult or uncomplicated-patient medication rule without accounting for the context in the stem.
What to expect on the PNLE
Pharmacology questions in this inventory support mechanism-to-effect reasoning, class or drug selection for a stated goal, interaction and contraindication screening, recognition of toxicity, and monitoring or patient teaching. A stem may present a new symptom after therapy, ask what finding requires priority action, test the purpose of a medication, or require the learner to connect a class with its therapeutic effect and major risk.
The live Bloom distribution is remembering=90, applying=90, understanding=26, evaluating=25, and analyzing=19. The live difficulty distribution is easy=75, medium=131, and hard=44. This supports practice that begins with accurate recall, moves to patient-specific application, and then asks learners to weigh competing cues, risks, and priorities.
Use the inventory to practice the cognitive work each item demands rather than memorizing isolated drug lists. Exact topic distribution varies by exam form.
- Remembering and understanding: retrieve mechanisms, class actions, therapeutic purposes, and characteristic monitoring needs.
- Applying: use the patient’s symptoms, medication history, and stated goal to choose a safe nursing decision.
- Analyzing and evaluating: compare plausible options, identify the most dangerous interaction or toxicity pattern, and prioritize the response that best protects the patient.
Study tips
- Start with diagnostic practice.
Complete a short mixed set without notes. For every missed or guessed item, label the gap as mechanism, class selection, interaction, toxicity, contraindication, monitoring, or time course. - Use focused retrieval.
Study one weak pharmacology area at a time, then close the notes and retrieve the drug class, mechanism, therapeutic goal, major risk, contraindication, monitoring priority, and patient-teaching point from memory. - Build a comparison grid.Class or drug | Mechanism | Therapeutic goal | Major danger | Contraindication or interaction | Monitoring | Time course
Complete one row for related classes, such as medications used for cardiovascular, psychotropic, endocrine, or neurologic purposes. Add a final column for the cue that would change your nursing priority. - Review rationales and errors.
For each error, write why the correct option fits the mechanism and why your choice failed. Record the cue you missed, the unsafe assumption, and the decision rule that should replace it. - Retry with spacing, then mix and time.
Return to the error log after a gap, retrieve the rules without looking, and answer a new focused set. Later, use mixed timed practice so you must shift between selection, interaction, toxicity, monitoring, and teaching decisions without topic labels.
Common mistakes to avoid
- Responding to the disease label instead of the drug-related cue.
A new severe symptom after pharmacotherapy may represent toxicity or an adverse effect. Correct the error by assessing timing, severity, associated findings, and the medication mechanism before choosing routine disease care. - Confusing a therapeutic goal with an immediate effect.
Questions involving antidepressants or acute anxiety can test whether the learner understands the intended outcome and time course. Correct the error by asking whether the medication is being used for immediate stabilization, ongoing symptom control, or a longer-term therapeutic goal. - Ignoring the medication history in interaction questions.
A patient taking an MAOI or another high-risk medication may develop danger from an added drug, product, or substance. Correct the error by screening the complete medication and substance list before accepting a seemingly appropriate selection. - Choosing a familiar cardiovascular intervention reflexively.
Hypotension after a medication such as sublingual nitroglycerin requires attention to the current hemodynamic cue and patient safety. Correct the error by reassessing stability and the medication effect before repeating therapy or focusing on the original diagnosis. - Treating monitoring findings as incidental.
Injection-site changes during insulin therapy or new symptoms during heart failure pharmacotherapy may affect safety and therapeutic evaluation. Correct the error by connecting the finding with drug response, absorption or tolerance concerns, glucose or other relevant trends, and the need for follow-up. - Applying a standard drug rule without patient-specific screening.
Renal or hepatic impairment, age, pregnancy or lactation, comorbidities, and polypharmacy can change medication risk. Correct the error by checking the patient factors in the stem and selecting the action that protects against the stated vulnerability.
Try a question
A real Pharmacology question from our bank. Give it a shot.
A patient receiving digoxin for heart failure begins to complain about unusual visual disturbances and a lack of appetite. What should the nurse suspect as the possible cause?
Digoxin is a cardiac glycoside widely used in the treatment of heart failure and certain arrhythmias. Its therapeutic window is narrow, meaning there is a fine line between effective and toxic doses. Patients on digoxin must be closely monitored for signs of toxicity, especially since several factors—including drug interactions and electrolyte disturbances—can precipitate adverse effects even at normal blood levels.
Why C is Correct: Visual disturbances (such as blurred vision, yellow-green halos, or photophobia) and gastrointestinal symptoms (such as anorexia, nausea, or vomiting) are classic early signs of digoxin toxicity. These symptoms can precede more severe manifestations such as life-threatening cardiac arrhythmias. Therefore, any report of unusual visual symptoms and loss of appetite in a patient taking digoxin should immediately prompt the nurse to suspect digoxin toxicity and notify the healthcare provider. Acting quickly can prevent progression to more serious complications.
| Common Early Signs of Digoxin Toxicity |
|---|
| Gastrointestinal disturbances: anorexia, nausea, vomiting |
| Visual changes: blurred vision, yellow-green halos |
| Fatigue, weakness |
Why the Other Options Are Incorrect:
| Option | Why It's Incorrect |
|---|---|
| A | Anxiety can cause vague symptoms like appetite changes, but it does not typically produce visual disturbances like those described. Visual changes are more specific to digoxin toxicity. |
| B | Low potassium (hypokalemia) increases sensitivity to digoxin and the risk of toxicity, but the symptoms described are not directly due to hypokalemia itself. While hypokalemia is a major risk factor, the symptoms presented point towards toxicity, not just low potassium. |
| D | Decreased cardiac output may cause fatigue or confusion, but does not characteristically lead to visual disturbances and anorexia. These specific symptoms are more closely tied to digoxin side effects. |
Nursing Concepts and Clinical Reasoning
- Nurses must understand the significance of early warning signs of drug toxicity and how to prioritize patient safety. Recognizing subtle symptoms allows for prompt intervention and prevents adverse outcomes.
- Monitoring for digoxin toxicity is a standard nursing responsibility when caring for patients on this medication. This includes regular assessment, educating the patient on what to watch for, and ensuring appropriate laboratory monitoring (serum digoxin and electrolyte levels).
Clinical Pearls:
- "Seeing green or yellow halos" is a classic memory aid for digoxin toxicity.
- Hypokalemia makes the heart more susceptible to digoxin's toxic effects, so potassium levels should be monitored closely.
- Always check apical pulse before administering digoxin, and withhold the drug if the pulse is below parameters set by facility policy or the provider.
Prompt recognition and intervention are critical components of safe medication administration, as highlighted in key nursing texts and examination standards.
- Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.
More Pharmacology questions
226 questions available. Sign up to practice all of them.
A patient treated with haloperidol develops a temperature of 40 °C, generalized rigidity, confusion, diaphoresis, and labile blood pressure. The team suspects neuroleptic malignant syndrome. Which action belongs to the medication-management portion of the emergency response?
A patient with acute cocaine toxicity is severely agitated, hyperthermic, and at risk for seizures. After supporting the airway and breathing, which plan should the nurse implement first?
A nurse is caring for a cancer patient receiving epoetin alfa injections. What is the primary purpose of administering this medication?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on September 20, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.